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doi:10.1016/j.kjms.2011.10.016Abstract As the applications for implantable medical devices have increased, the need for
biocompatible packaging materials has become important. Recently, we reported an implant-
able sensor for real-time monitoring of the changes in bladder volume, which necessitated
finding a safe coating material for use in bladder tissue. At present, materials like polyethylene
glycol (PEG), polydimethylsiloxane (PDMS) and parylene-C are used in biomedical devices or as
coating materials, owing to their excellent safety in various medical fields. However, few
studies have assessed their safety in bladder tissue, therefore, we evaluated the biocompati-
bility of PEG, PDMS and parylene-C in the bladder. All three materials turned out to be safe in
in vitro tests of live/dead staining and cell viability. In vivo tests with hematoxylin and eosin
and immunofluorescence staining with MAC387 showed no persistent inflammation. Therefore,
we consider that the three materials are biocompatible in bladder tissue. Despite this safety,
however, PEG has biodegradable characteristics and thus is not suitable for use as packaging.
We suggest that PDMS and parylene-C can be used as safe coating materials for the implantable
bladder volume sensor reported previously.
Copyright ª 2012, Elsevier Taiwan LLC. All rights reserved.Introduction
The development of implantable medical devices has led to
improvement in the treatment of patients with chronicof Urology, Seoul St. Mary’s
Seoul 137-701, South Korea.
.ac.kr (S.-W. Kim).
vier Taiwan LLC. All rights reservdiseases. For example, an implantable medical device such
as a pacemaker can control arrhythmia that does not
respond to medical treatment. Such devices can improve
the quality of life. Therefore, great efforts have been made
to invent implantable medical devices in various medical
fields including urology.
Neurogenic bladder is one of the voiding dysfunctions
caused by disorders of the nervous system, such as cerebral
attack or hemorrhage, spinal cord injury, and diabetesed.
124 S.-J. Kim et al.mellitus. In these patients, monitoring of intravesical
pressure is important for protecting renal function, there-
fore, some studies have reported the use of implantable
devices for monitoring intravesical pressure or changes of
the bladder in animals [1e3].
Before an implantable device can be used clinically, not
only efficacy but also safety should be evaluated. Gener-
ally, materials like polyethylene glycol (PEG) and poly-
dimethylsiloxane (PDMS) are used to coat the implantable
device safely [4,5]. In addition, parylene-C has recently
been suggested as another safe coating material [6].
We previously have reported on the usefulness of
a bladder volume sensor in small animals [3]. For this sensor
to be used in clinical applications, appropriate, safe pack-
aging materials for the bladder volume sensor are necessary.
Materials such as PEG, PDMS and parylene-C can be used to
coat the implantable device: however, few studies have
evaluated their safety as coating materials in bladder tissue.
Accordingly, in the present study, we evaluated the
safety of PEG, PDMS and parylene-C in rabbit bladder.
Materials and methods
Study design
The research was conducted in accordance with the
National Institutes of Health guidelines on care and use of
laboratory animals, and was approved by the Catholic
Animal Ethics Committee (Catholic University Medical
College 2010-0115-03).
Preparation of coating materials
We investigated the biocompatibility of three coating
materials: PEG, PDMS and parylene-C. A coin-shaped piece
of aluminum was coated with PEG, PDMS or parylene-C.
Coin-shaped pieces of aluminum without packaging were
used as controls (n Z 3).
Coating with PEG, PDMS or parylene-C
PEG solution was prepared by using 99% (by wt%) PEG
(molecular weight 258; Aldrich) and 1% (by wt%) hydrophilic
2-hydroxy-2-methylpropiophenone photoinitiator (Aldrich)
[7]. The aluminum coin was then immersed in the PEG solu-
tion (molecular weight 258; Sigma-Aldrich, St. Louis, USA)
and exposed to 250e400 nm ultraviolet light for seconds.Figure 1. Coin-shaped pieces of aluminum coated with polyethy
to the external bladder wall.The aluminum coin was immersed in PDMS solution
(Sylgard 184; Dow Corning, Seoul, Korea; silicone elas-
tomer: curing agent Z 10: 1), and heated at 80 C for 2
hours.
Parylene-C was vaporized at 1 barometric pressure and
150 C. Even at 0.5 vaporized pressure and 690 C, the heat
degradation reaction was maintained, and at that time,
parylene-C was converted to the monomer para-xylene. It
was polymerized to poly-para-xylene at 0.1 barometric
pressure and 35 C, and this was used to coat the aluminum
coin. The coating reaction was carried out with the Nuricell
Parylene coating system (NPCR-400; Nuricell, Seoul, Korea),
as described previously [8].
Implantation of coated aluminum coins
Twelve New Zealand male rabbits (2.5e3 kg) were used.
The rabbits were assigned to three experimental groups of
three animals each: PEG, PDMS and parylene-C. The rabbits
were anesthetized by the intramuscular injection of 10 mg/
kg xylazine (Bayer Korea, Seoul, Korea) and 25 mg/kg ket-
amine (Yoo Han Yang Hang, Seoul, Korea). The bladder was
then exposed by midline incision, and the aluminum coins
coated with PEG, PDMS, or parylene-C were attached to the
external wall of the bladder by use of 4-0 polydioxanone
(Fig. 1). Sham operation was performed in the control group
(n Z 3) in the same manner.
In vitro cytotoxicity test
Live/dead staining
To study the cytotoxicity of the packaging materials,
NIH3T3 fibroblasts were used as the model cell. NIH3T3
cells were expanded in T-175 flasks supplemented with
Dulbecco’s Modified Eagle’s Medium (DMEM) containing 10%
fetal bovine serum and 1% penicillin/streptomycin. Pack-
aging materials on 1-cm discs were fitted into a six-well
tissue culture plate. To evaluate cell viability, NIH3T3
cells were seeded at a density of 105 cells/mL on the
surface of the packaging materials. After incubation for
a predetermined time, the medium was removed and the
packaging materials were washed twice in phosphate-
buffered saline (PBS). Live and dead cells were assessed
by use of the LIVE/DEAD Viability/Cytotoxicity Assay Kit
(Molecular Probes, Carlsbad, CA, USA). Cultured packaging
materials were incubated in assay reagents containing
2 mM calcein AM (labeled live cells) and 4 mM ethidiumlene glycol, polydimethylsiloxane or parylene-C were attached
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rials were incubated in a covered dish to prevent drying of
the samples for about 45 minutes at 37 C. The live and
dead cell images were taken with an LSM 510 confocal
microscope (LSM510 META, Carl Zeiss, Germany).
Cell viability
The cytotoxicity test of the prepared packaging materials
was determined by cell counting with trypan blue. In the
dynamic condition, an extract of the test sample (PEG,
PDMS or parylene-C) was made by immersing the test
sample into DMEM containing 100 U/mL penicillin, 100 g/mL
streptomycin, and 10% fetal bovine serum in an incubator at
37 C in a humidified atmosphere of 5% CO2 for 24 hours.
First, NIH3T3 fibroblasts (106/well) were plated in six-well
plates and incubated for 24 hours. Then, the medium was
aspirated and the plates were rinsed twice with PBS. The
extract of the test sample was added to each well, and the
plates were incubated for 24 hours. The cells detached by
trypsin/EDTA were stained with 500 mL 4% trypan blue
(Gibco, Carlsbad, CA, USA). The living cells were subse-
quently counted in a hemocytometer.
In vivo cytotoxicity tests
Hematoxylin and eosin staining
Rabbits were sacrificed after 1, 2 and 4 weeks, and tissues
attached to the aluminum coated with PDMS, PEG or
parylene-C were collected, and fixed in 10% neutral
formalin for 1 day. For the preparation of the fixed tissues
as samples for light microscopy, the tissues were dehy-
drated with alcohol, embedded in paraffin, sectioned in
5-mm sections with a microtome, and stained with hema-
toxylin and eosin (H&E). Histological images of the implan-
tation site were obtained by use of a light microscope at 40
magnification. Neovascularization was observed at 400
magnification. The degree of neovascularization was
assessed in a semiquantitative way by using a modified
histological scale [9] (Table 1).
Immunofluorescence staining for macrophages
Rabbits were sacrificed and the bladder attached with PEG,
PDMA, or parylene-C e coated aluminum coin of each rabbit
was excised after 1, 2 and 4 weeks and then washed with
ethanol for 5 minutes. The slides were added to 0.01%
sodium citrate (pH 6), boiled in a microwave oven, and
cooled for 20 minutes at room temperature. To inhibit
nonspecific reactions during staining, the slides were reac-
ted with a blocking solution (1.5% normal goat serum, 1.5%Table 1 Histological scoring scale.
Score Inflammation Collage
0 None Disorgan
1 Minimalemild Slightly
2 Moderate Moderat
3 Severe Well org
Hpf Z high-power field.normal horse serum, 1% bovine serum albumin, 0.1% Triton
X-100 in PBS) at room temperature for 1 hour, and were
reacted with the primary antibody MAC387 (Abcam, Cam-
bridge, UK) at room temperature for 2 hours. The slides
were then washed with PBS three times, and reacted at
room temperature for 1 hour with the secondary antibody
(Alexa Fluor 568 goat anti-mouse IgG; Invitrogen, Carlsbad,
CA, USA) diluted to 1:500 with the blocking solution. The
slides were then washed with PBS three times, and mounted
with 40,6-diamidino-2-phenylindole, and images were ob-
tained with a fluorescence microscope.
Data analysis
The data were analyzed statistically by using one-way
analysis of variance and were expressed as the mean 
standard deviation. The data of each group were compared
by using the NewmaneKeuls’ multiple comparison test.
Significance was set at p < 0.05.Results
In vitro cytotoxicity
As shown by the results of the live/dead staining, the
expression of live cells in the PEG, PDMS and parylene-C
groups was similar to that in the controls, and dead cells
were rarely observed. Cell viability was >80% in each of the
three groups, which was the same as for the controls (Fig. 2).In vivo cytotoxicity
Histological findings
We observed that the aluminum coins coated with PEG,
PDMS or parylene-C were implanted well in the bladder.
H&E staining at 1 week after implantation showed the
presence of inflammatory cells resulting from the early
inflammatory response (Fig. 3). The formation of new blood
vessels was noted in the PEG, PDMS and parylene-C groups
compared with the controls after 1 week. The degree of
neovascularization, however, was mild in all three groups
(Fig. 4).
Immunofluorescence findings
Immunofluorescence staining with MAC387 showed mild
expression of macrophages in the implantation site in the
PEG, PDMS and parylene-C groups compared with the
controls after 1 week. A decrease in expression ofn organization Vascularity
ized None (No vessel/hpf)
organized Minimal (1e3 vessels/hpf)
ely organized Moderate (4e10 vessel/hpf)
anized
Figure 2. In vitro cytotoxicity test. (A) LIVE/DEAD staining. Green: live cell; red: dead cell (scale bar: 50 mm). (B) Cell viability.
PEG Z polyethylene glycol; PDMS Z polydimethylsiloxane.
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macrophages were rarely expressed in all three groups
(Fig. 5).Discussion
The results of the present study showed that PEG, PDMS and
parylene-C seemed to be safe for use as coating materialsFigure 3. Histological findings at 1 week after implantation. Arro
eosin, 40). PEG Z polyethylene glycol; PDMS Z polydimethylsiloin bladder tissue. Therefore, these materials could be used
to package a pressure or volume sensor in the bladder.
Neurogenic bladder is a voiding dysfunction caused by
disorders in the central or peripheral nervous system, such
as cerebrospinal disease or injury, diabetes mellitus, or
complications after radical pelvic surgery [10,11]. Accord-
ing to the characteristics of the voiding status of the
neurogenic bladder, it can be divided into hyperreflexic and
underactive or acontractile neurogenic bladder. Of thesew: implantation site and inflammatory cells, (hematoxylin and
xane.
Figure 4. (A) Neovascularization at 1 week after implantation. Arrow: formation of new blood vessels near the implantation site
(hematoxylin and eosin, 40). (B) Number of new blood vessels. *p < 0.05 compared with normal tissue. PEG Z polyethylene
glycol; PDMS Z polydimethylsiloxane.
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changes in bladder volume in patients with underactive or
acontractile neurogenic bladder [12]. Usually, these
patients cannot recognize distension over their normal
bladder capacity. As a result, normal voiding is not able to
occur and, moreover, repetition of inappropriate voiding
causes deterioration of renal function. We have previously
reported development of a real-time implantable bladder
volume sensor that was attached to both sides of the
outside wall of the bladder [3]. Undoubtedly, safety is
a significant factor in the design of an implantable medical
device. Many studies on the safety of PEG, PDMS and
parylene-C as packaging materials in various organs have
been done, and the safety of these materials has beenFigure 5. (A) Immunofluorescence staining with MAC387. Red: m
staining), 100. Arrow: macrophage near the implantation site. (
rial. *p < 0.01. PEG Z polyethylene glycol; PDMS Z polydimethylsdemonstrated [13e16]. However, evaluation of safety has
rarely been done in the bladder.
According to the present in vitro results with live and
dead staining, almost all of the cells in the PEG, PDMS and
parylene-C groups appeared as live cells. Moreover, all of
the three materials showed excellent viability by cell
culture. This finding is similar to previous research on the
safety of these three materials [17e19].
After implantation of a medical device, an inflammatory
reaction occurs against the foreign body. In the early
phase, the biomaterial-mediated inflammatory response is
modulated by histamine-mediated macrophage recruit-
ment and adhesion to the implant surface [20]. Next,
mononuclear cells such as monocytes and lymphocytes areacrophage; blue: cell nucleus (40,6-diamidino-2-phenylindole
B) Number of MAC387-positive cells on each packaging mate-
iloxane.
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phase. If the implant device is biocompatible, early reso-
lution of the acute and chronic inflammation responses
occurs. The persistence of inflammatory responses for
longer than 3 weeks usually indicates an infection [20,21].
In the present study, inflammatory cells were observed
only in the area adjacent to the implants, and these changes
were not significantly different from the controls, as shown
by H&E staining after 1 week. In addition, we noted only
mild neovascularization in the area adjacent to the implants
coated with PEG, PDMS or parylene-C, by H&E staining. The
formation of new blood vessels was not observed after 4
weeks. These findings suggest that PEG, PDMS and parylene-
C are safe as coating materials in bladder tissue.
According to the results of the immunofluorescent
staining with MAC387, a mild increase in the expression of
macrophages was noted in the rabbit bladder tissues that
were in contact with the coated implants after 1 week.
These changes were not significantly different from those in
the controls. After 2 weeks, expression of macrophages
seemed to decrease, and macrophages were rarely observed
after 4 weeks. As previously mentioned, macrophages play
an important role in the inflammatory reaction against
foreign bodies [20,21]. The decrease in the expression of
macrophages after 4 weeks suggests that PEG, PDMS and
parylene-C were not the cause of infection and, therefore,
all three materials seem to be biocompatible.
The inflammatory response did not persist in the rabbit
bladder tissue incontactwithPEG,PDMSorparylene-Cbeyond
3weeks. For these reasons, PEG, PDMS and parylene-Cmay all
be appropriate packaging materials for the implantable
bladder volume sensor that we have reported previously [3].
Among the three materials we used in our study, PEG is
not supposed to be suitable as a packaging material because
it has biodegradable characteristics [22,23]. Nevertheless,
we chose PEG as one of our study materials because of its
excellent biocompatibility compared with other polymers.
PEG has cationic and hydrophilic characteristics, therefore,
it inhibits early and late macrophage adhesion and then
inhibits lymphocyte proliferation for longer times [24e26].
Therefore, PEG is considered to have good biomaterial
surface chemistry. In the present study, the inflammatory
responses of PDMS and parylene-C were similar to those for
PEG; therefore, we conclude that PDMS and parylene-C may
show the same safety profile as PEG in rabbit bladder tissue.
Meanwhile, there are some differences between PDMS and
parylene-C. For example, PDMS shows more elasticity than
parylene-C does. In contrast, parylene-C may have better
characteristics with regard to the coating process. There-
fore, it is necessary to consider which material is appro-
priate according to the shape and characteristics of the
various implantable sensors in the bladder.
A limitation of the present study was that we evaluated
only the short-term safety of PDMS and parylene-C coating
materials in the bladder tissue. Thus, more studies about
the long-tem safety are necessary to determine the ideal
packaging materials for clinical application.
In conclusion, we suggest that PDMS and parylene-C can
be used as biocompatible packaging materials for the
implantable bladder volume sensor. For clinical application,
further study of the long-term safety of PDMS and parylene-
C appears to be necessary.Acknowledgments
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